arginine has been researched along with Acute Lymphoid Leukemia in 79 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 6 (7.59) | 18.7374 |
1990's | 46 (58.23) | 18.2507 |
2000's | 20 (25.32) | 29.6817 |
2010's | 7 (8.86) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Beggs, A; Booth, S; Cheng, P; Cousins, A; De Santo, C; Halsey, C; Kearns, P; Mussai, F; Ng, M; Noyvert, B; Perry, T; Tubb, V; Vardon, A | 1 |
Huml, M; Jehlička, P; Kreslová, M; Masopustová, A; Sýkora, J; Trefil, L; Votava, T | 1 |
Bari, R; Gan, K; Kang, G; Leung, W; Rujkijyanont, P; Sullivan, E; Turner, V | 1 |
Chybicka, A; Doroszko, A; Jakubowski, M; Mazur, G; Niedzielska, E; Porwolik, J; Szahidewicz-Krupska, E; Szuba, A; Turek-Jakubowska, A | 1 |
Balwierz, W; Ćwiklińska, M; Grodzicki, TK; Gryglewska, B; Kwater, A; Strach, M; Sulicka, J; Surdacki, A | 1 |
Ahrén, B; Björk, J; Cavallin-Ståhl, E; Erfurth, EM; Garwicz, S; Link, K; Moëll, C; Thilén, U | 1 |
Björk, J; Erfurth, EM; Link, K | 1 |
Haddy, TB; Mosher, RB; Nunez, SB; Reaman, GH | 1 |
Baralle, D; Bonthron, DT; Charlton, R; Cole, TR; De Vos, M; Glaser, AW; Hayward, BE; Maher, ER; Mann, JR; McKeown, CM; Picton, S; Rankin, J; Sheridan, E; Taylor, GR; Yates, JR | 1 |
Catherwood, MA; McMullin, MF; Winter, PC | 1 |
Albertoni, C; Arrigoni Martelli, E; De Simone, C; Famularo, G; Foresta, P | 1 |
Faller, DV; Fingeroth, J; Mentzer, SJ; Perrine, SP; Reilly, JJ | 1 |
Brennan, BM; Eden, OB; Mackie, EM; Rahim, A; Shalet, SM | 1 |
Davenport, DJ; Fettman, MJ; Gross, KL; Hand, MS; Hansen, RA; Mallinckrodt, CH; Ogilvie, GK; Richardson, KL; Rogers, Q; Walton, JA | 1 |
Cusack, BJ; Dai, R; Friedman, FK; Hadjokas, NE; Ma, Y; Spence, MJ; Vestal, RE | 1 |
Bozzola, M; Cisternino, M; Gambarana, D; Giorgiani, G; Locatelli, F; Moretta, A; Severi, F; Valtorta, A | 1 |
Balsamo, A; Cacciari, E; Cau, M; Cicognani, A; Paolucci, G; Pirazzoli, P; Rosito, P; Tosi, MT; Vecchi, V | 1 |
Asselin, BL; Bell, BA; Camitta, BM; Chauvenet, A; Devidas, M; Halperin, EC; Jones, TL; Kurtzberg, J; Pullen, J; Shuster, JJ; Tower, RL; Winick, N | 1 |
Brassesco, MS; Camparoto, ML; Gras, DE; Martinez-Rossi, NM; Montaldi, AP; Sakamoto-Hojo, ET; Scrideli, CA; Tone, LG | 1 |
Buchanan, GR; Camitta, B; Devidas, M; Joyce, MJ; Pollock, BH | 1 |
Crocci, AJ; Lopes, LF; Minicucci, EM | 1 |
Hirschfeld, S; Ho, PT; Pazdur, R; Smith, M | 1 |
Fang, CQ; Li, HF; Shi, SW; Song, H; Tang, YM; Xu, WQ; Yang, SL | 1 |
Bao, L; Huang, XJ; Jiang, B; Lu, DP; Lu, J; Lu, XJ; Qiu, JY; Shi, HX; Wang, DB; Wang, FR | 1 |
Campana, D; Cheng, C; Downing, JR; Evans, WE; Hijiya, N; Howard, SC; Hudson, M; Jeha, S; Pei, D; Pui, CH; Razzouk, BI; Relling, MV; Ribeiro, RC; Rubnitz, JE; Sandlund, JT | 1 |
Hijiya, N; Howard, SC; Hudson, MM; Jeha, S; Kyzer, EP; Panetta, JC; Pui, CH; Razzouk, BI; Relling, MV; Ribeiro, RC; Rubnitz, JE; Sandlund, JT; Zhou, Y | 1 |
Selleslag, D | 1 |
Abella, E; Bethencourt, C; Brunet, S; Debén, G; del Potro, E; Feliu, E; Hernández-Rivas, JM; López, R; Morgades, M; Novo, A; Oriol, A; Ortega-Rivas, F; Ortín, X; Ribera, JM; Sancho, JM; Sanz, MA; Tormo, M; Xicoy, B | 1 |
Broekema, G; Giaccone, G; Kaspers, GJ; Klumper, E; Pieters, R; van Ark-Otte, J; van Wering, ER; Veerman, AJ | 1 |
Evans, WE; Liu, Q; McLeod, HL; Pui, CH; Relling, MV | 1 |
Felix, CA; Hosler, MR; Lange, BJ; Masterson, M; Wilson, AE; Winick, NJ | 1 |
Crist, WM; Pratt, CB; Pui, CH; Rivera, GK; Santana, VM | 1 |
Chan, LC; Chan, TK; Chiu, EK; Kwong, YL; Liang, R; Lie, A; Todd, D | 1 |
Meyer, C | 1 |
Gururangan, S; Horner, M; Marina, NM; Rodman, JH | 1 |
Baker, D; Fairclough, D; Mulhern, RK; Pui, CH; Relling, MV | 1 |
Büchner, T; Freund, M; Heil, G; Hiddemann, W; Hoelzer, D; Löffler, H; Ludwig, WD; Maschmeyer, G; Thiel, E; Völkers, B | 1 |
Andrea, M; Aranega, V; Brandalise, S; Odone, V; Pereira, W; Zanichelli, M | 1 |
Fairclough, D; Longmire, W; Mulhern, RK; Relling, MV; Tyc, VL; Ward, PM | 1 |
Evans, WE; Furman, WL; Rivera, G; Rodman, JH; Sunderland, M | 1 |
Buchanan, GR; Rivera, GK; Sadowitz, PD; Shuster, J; Smith, SD; Wharam, MD | 1 |
Adair, S; Camitta, BM; Casper, JT; Civin, CI; Graham, M; Kiefer, G; Lauer, SJ; Leventhal, BG; Mahoney, DH; Shuster, JJ | 1 |
Benaim, E; Crist, WM; Hudson, MM; Liu, Q; Pui, CH; Ribeiro, RC; Rivera, GK | 1 |
Cardenas-Cardos, R; Gómez-Martínez, R; Leal-Leal, C; Meza-Coria, C; Navarro-Alegría, I; Rivera-Luna, R; Vega-Vega, L | 1 |
Andreev, IO; Kolotova, TY; Kunakh, VA; Pogribniy, PV; Solov'yan, VT; Tarnavsky, DT | 1 |
Boyett, JM; Crom, WR; Evans, WE; Pui, CH; Relling, MV; Rodman, JH | 1 |
Boyett, JM; Buchanan, GR; Chauvenet, AR; Crist, WM; Maybee, DA; Pinkel, D; Pollock, BH; Rivera, GK; Wagner, H | 1 |
Estlin, EJ; Hall, AG; Lowis, SP | 1 |
Huismans, DR; Pieters, R; Schuurhuis, GJ; Styczynski, J; Veerman, AJ; Wysocki, M | 1 |
Deelman, BG; Kamps, WA; Kingma, A; Mooyaart, EL; Van Dommelen, RI; Wilmink, JT | 1 |
Beck, WT; Danks, MK; Granzen, B; Wolverton, JS | 1 |
Evans, WE; Rivera, GK | 1 |
Nowaczyk-Michalak, A; Pilecki, O; Wysocki, M | 1 |
Crist, WM; Crom, WR; Evans, WE; Groom, S; McLeod, HL; Relling, MV; Rivera, GK; Rodman, JH; Silverstein, K | 1 |
Christensen, M; Evans, WE; Petros, WP; Pui, CH; Relling, MV; Rivera, GK; Rodman, JH | 1 |
Beck, WT; Bugg, BY; Danks, MK; Suttle, DP | 1 |
Castel, V; Esquembre, C; Fernandez, JM; Ferris, J; Prieto, F; Ruiz, JG; Tasso, MJ; Verdeguer, A | 1 |
Evans, WE; Petros, WP; Pui, CH; Relling, MV; Rivera, GK; Rodman, JH; Stewart, CF | 1 |
Baker, DK; Christensen, ML; Evans, WE; Pui, CH; Relling, MV; Rodman, JH | 1 |
Baker, DK; McLeod, HL; Pui, CH; Rodman, JH | 1 |
Behm, FG; Evans, WE; Hancock, ML; Head, DR; Mahmoud, MH; Pui, CH; Raimondi, SC; Ribeiro, RC; Rivera, GK; Sandlund, JT | 1 |
Abromowitch, M; Harris, M; Kavanagh, R; Ochs, J; Rivera, GK; Rodman, J; Yalowich, J | 1 |
Crist, WM; Crone, ME; Fairclough, DL; Kellie, SJ; Pui, CH; Rivera, GK; Rodman, JH | 1 |
Boyett, JM; Buchanan, GR; Crist, WM; Ghim, T; Johnson, W; Pollock, BH; Smith, SD; Vietti, TJ; Wharam, MD; Yanofsky, RA | 1 |
De Boben, M; Diedrich, H; Freund, M; Ganser, A; Heil, G; Henke, M; Heyll, A; Hiddemann, W; Knauf, U; Koch, P | 1 |
Goebel, U; Graubner, U; Haas, RJ; Janka-Schaub, GE; Juergens, H; Spaar, HJ; Winkler, K | 1 |
Björkholm, M | 1 |
Evans, WE; Kavanagh, RL; Ochs, J; Rivera, GK; Rodman, JH; Sunderland, M; Yalowich, J | 1 |
Bartsch, CH; Gadner, H; Martins da Cunha, AC | 1 |
Buchanan, G; Crist, W; Freeman, AI; Ochs, J; Pollock, BH; Rivera, GK | 1 |
Belasco, JB; Luery, N; Scher, C | 1 |
Bladé, J; Carreras, E; Cervantes, F; Grañena, A; Marín, P; Nomdedeu, B; Ribera, JM; Rozman, C; Sierra, J; Urbano-Ispizua, A | 1 |
Beck, WT; Danks, MK; Deneka, DA; Schmidt, CA | 1 |
Dahl, GV; Grier, HE; Kalwinsky, DK; Mason, C; Mirro, J; Murphy, SB; Santana, VM | 1 |
Abromowitch, M; Evans, WE; Fairclough, D; Hustu, HO; Kalwinsky, D; Look, AT; Murphy, SB; Ochs, J; Pui, CH; Rivera, GK | 1 |
Bezanilla Regato, JL; Moya Calderón, E; Navajas Gutiérrez, A; Piñán, MA | 1 |
Boyett, J; Buchanan, GR; Murphy, SB; Winick, N; Yu, A | 1 |
6 review(s) available for arginine and Acute Lymphoid Leukemia
Article | Year |
---|---|
Regulatory approvals of pediatric oncology drugs: previous experience and new initiatives.
Topics: Antineoplastic Agents; Azacitidine; Child; Child, Preschool; Drug Approval; Humans; Leukemia, Myeloid, Acute; Methotrexate; Neuroblastoma; Osteosarcoma; Pediatrics; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Teniposide; United States; United States Food and Drug Administration; Vindesine | 2003 |
Epipodophyllotoxins in the treatment of childhood cancer.
Topics: Antineoplastic Combined Chemotherapy Protocols; Child; Clinical Trials, Phase I as Topic; Clinical Trials, Phase II as Topic; Cytarabine; Etoposide; Humans; Leukemia, Myeloid, Acute; Lymphoma, Non-Hodgkin; Neoplasms; Neoplasms, Second Primary; Neuroblastoma; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Teniposide | 1994 |
Optimizing antimetabolite-based chemotherapy for the treatment of childhood acute lymphoblastic leukaemia.
Topics: Antimetabolites, Antineoplastic; Child; Cytarabine; Drug Administration Schedule; Etoposide; Humans; Mercaptopurine; Methotrexate; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Teniposide; Thioguanine | 2000 |
Clinical trials of teniposide (VM-26) in childhood acute lymphocytic leukemia.
Topics: Antineoplastic Combined Chemotherapy Protocols; Child; Humans; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Remission Induction; Teniposide | 1992 |
Disposition of antineoplastic agents in the very young child.
Topics: Age Factors; Antineoplastic Agents; Blood Proteins; Child; Child, Preschool; Doxorubicin; Etoposide; Humans; Infant; Infant, Newborn; Liver; Mercaptopurine; Methotrexate; Neoplasms; Nervous System; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Teniposide | 1992 |
Etoposide and teniposide in the treatment of acute leukemia.
Topics: Antineoplastic Combined Chemotherapy Protocols; Etoposide; Humans; Leukemia, Myeloid, Acute; Podophyllotoxin; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Teniposide | 1990 |
21 trial(s) available for arginine and Acute Lymphoid Leukemia
Article | Year |
---|---|
Effect of fish oil, arginine, and doxorubicin chemotherapy on remission and survival time for dogs with lymphoma: a double-blind, randomized placebo-controlled study.
Topics: Animals; Antineoplastic Agents; Arginine; Cachexia; Diet; Dietary Supplements; Disease Models, Animal; Disease-Free Survival; Docosahexaenoic Acids; Dogs; Dose-Response Relationship, Drug; Double-Blind Method; Doxorubicin; Eicosapentaenoic Acid; Fatty Acids; Fish Oils; Lactic Acid; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Survival Analysis | 2000 |
Dose intensification of methotrexate and cytarabine during intensified continuation chemotherapy for high-risk B-precursor acute lymphoblastic leukemia: POG 9406: a report from the Children's Oncology Group.
Topics: Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Child; Cytarabine; Dose-Response Relationship, Drug; Female; Follow-Up Studies; Humans; Male; Methotrexate; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Prognosis; Remission Induction; Risk Factors; Survival Rate; Teniposide | 2014 |
Body mass index does not influence pharmacokinetics or outcome of treatment in children with acute lymphoblastic leukemia.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Body Mass Index; Child; Child, Preschool; Cytarabine; Disease-Free Survival; Female; Humans; Infant; Male; Mercaptopurine; Methotrexate; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Predictive Value of Tests; Remission Induction; Retrospective Studies; Teniposide | 2006 |
Results of the PETHEMA ALL-96 trial in elderly patients with Philadelphia chromosome-negative acute lymphoblastic leukemia.
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Comorbidity; Cyclophosphamide; Cytarabine; Daunorubicin; Dexamethasone; Disease-Free Survival; Female; Follow-Up Studies; Granulocyte Colony-Stimulating Factor; Humans; Kaplan-Meier Estimate; Male; Mercaptopurine; Methotrexate; Middle Aged; Neutropenia; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Prednisone; Prognosis; Remission Induction; Severity of Illness Index; Survival Analysis; Teniposide; Treatment Outcome; Vincristine | 2007 |
Chlorpromazine with and without lorazepam as antiemetic therapy in children receiving uniform chemotherapy.
Topics: Adolescent; Antiemetics; Antineoplastic Combined Chemotherapy Protocols; Child; Child, Preschool; Chlorpromazine; Cytarabine; Double-Blind Method; Drug Therapy, Combination; Female; Humans; Infant; Lorazepam; Male; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Remission Induction; Teniposide; Vomiting | 1993 |
Follow-up of the first two successive German multicentre trials for adult ALL (01/81 and 02/84). German Adult ALL Study Group.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Cranial Irradiation; Cyclophosphamide; Cytarabine; Daunorubicin; Doxorubicin; Drug Administration Schedule; Follow-Up Studies; Humans; Mediastinum; Mercaptopurine; Methotrexate; Middle Aged; Pilot Projects; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Prednisone; Prospective Studies; Remission Induction; Survival Analysis; Teniposide; Vincristine | 1993 |
Treatment results of three consecutive Brazilian cooperative childhood ALL protocols: GBTLI-80, GBTLI-82 and -85. ALL Brazilian Group.
Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Child; Cranial Irradiation; Cyclophosphamide; Cytarabine; Daunorubicin; Dexamethasone; Drug Administration Schedule; Humans; Methotrexate; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Prednisone; Prognosis; Remission Induction; Teniposide; Vincristine | 1993 |
Chemotherapy induced nausea and emesis in pediatric cancer patients: external validity of child and parent emesis ratings.
Topics: Adolescent; Antiemetics; Antineoplastic Combined Chemotherapy Protocols; Anxiety; Attitude; Child; Child, Preschool; Cytarabine; Double-Blind Method; Female; Humans; Infant; Male; Nausea; Parents; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Severity of Illness Index; Sick Role; Teniposide; Vomiting | 1993 |
Treatment of late bone marrow relapse in children with acute lymphoblastic leukemia: a Pediatric Oncology Group study.
Topics: Antineoplastic Combined Chemotherapy Protocols; Bone Marrow; Child; Child, Preschool; Cytarabine; Female; Humans; Leukocyte Count; Male; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Recurrence; Retrospective Studies; Teniposide; Time Factors; Treatment Failure | 1993 |
B-lineage acute lymphoblastic leukemia of childhood. An institutional experience.
Topics: Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Burkitt Lymphoma; Child; Child, Preschool; Cytarabine; Disease-Free Survival; Female; Humans; Immunophenotyping; Infant; Life Tables; Male; Mercaptopurine; Methotrexate; Neprilysin; Precursor B-Cell Lymphoblastic Leukemia-Lymphoma; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Prednisone; Prognosis; Risk Factors; Survival Analysis; Teniposide; Treatment Outcome; Vincristine | 1997 |
Conventional compared with individualized chemotherapy for childhood acute lymphoblastic leukemia.
Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Child; Child, Preschool; Cytarabine; Female; Humans; Infant; Leukemia, B-Cell; Male; Metabolic Clearance Rate; Methotrexate; Patient Care Planning; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Proportional Hazards Models; Prospective Studies; Remission Induction; Survival Analysis; Teniposide | 1998 |
Alternating drug pairs with or without periodic reinduction in children with acute lymphoblastic leukemia in second bone marrow remission: a Pediatric Oncology Group Study.
Topics: Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Bone Marrow Transplantation; Child; Cyclophosphamide; Cytarabine; Daunorubicin; Humans; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Prednisone; Recurrence; Remission Induction; Teniposide; Vincristine | 2000 |
Acute myeloid leukemia in children treated with epipodophyllotoxins for acute lymphoblastic leukemia.
Topics: Acute Disease; Adolescent; Child; Child, Preschool; Drug Administration Schedule; Etoposide; Humans; Leukemia, Myeloid; Neoplasms, Second Primary; Podophyllotoxin; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Remission Induction; Risk Factors; Teniposide | 1991 |
A phase II study of combined methotrexate and teniposide infusions prior to reinduction therapy in relapsed childhood acute lymphoblastic leukemia: a Pediatric Oncology Group study.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Child; Drug Evaluation; Humans; Methotrexate; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Recurrence; Remission Induction; Teniposide | 1991 |
Improved treatment results in boys with overt testicular relapse during or shortly after initial therapy for acute lymphoblastic leukemia. A Pediatric Oncology group study.
Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Child; Child, Preschool; Combined Modality Therapy; Cyclophosphamide; Cytarabine; Daunorubicin; Humans; Infant; Male; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Prednisone; Recurrence; Remission Induction; Risk Factors; Survival Rate; Teniposide; Testicular Neoplasms; Vincristine | 1991 |
Treatment of relapsed acute lymphocytic leukemia in adults.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Bone Marrow Transplantation; Brain Neoplasms; Combined Modality Therapy; Cytarabine; Daunorubicin; Dexamethasone; Etoposide; Female; Germany, West; Humans; Ifosfamide; Leucovorin; Life Tables; Male; Methotrexate; Middle Aged; Multicenter Studies as Topic; Neoplasm Recurrence, Local; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Prednisone; Spinal Cord Neoplasms; Teniposide; Testicular Neoplasms; Vindesine | 1990 |
Improved prognosis for childhood acute lymphocytic leukemia with very high white blood cell count (greater than 100/nl) with rotation of non-cross-resistant drug combinations.
Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Child; Child, Preschool; Combined Modality Therapy; Cyclophosphamide; Cytarabine; Daunorubicin; Dexamethasone; Germany, West; Humans; Infant; Infant, Newborn; Leukocyte Count; Mercaptopurine; Methotrexate; Multicenter Studies as Topic; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Prednisone; Prognosis; Randomized Controlled Trials as Topic; Risk; Survival Rate; Teniposide; Thioguanine; Vincristine | 1990 |
Pharmacokinetics of continuous infusion of methotrexate and teniposide in pediatric cancer patients.
Topics: Antineoplastic Combined Chemotherapy Protocols; Child; Clinical Trials as Topic; Drug Administration Schedule; Humans; Infusions, Intravenous; Leucovorin; Metabolic Clearance Rate; Methotrexate; Podophyllotoxin; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Teniposide | 1990 |
Teniposide (VM-26) and continuous infusion cytosine arabinoside for initial induction failure in childhood acute lymphoblastic leukemia. A Pediatric Oncology Group pilot study.
Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Child; Child, Preschool; Cytarabine; Female; Humans; Hydrocortisone; Infant; Infusions, Intravenous; Male; Methotrexate; Pilot Projects; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Remission Induction; Teniposide; United States | 1990 |
[Adult acute lymphoblastic leukemia: preliminary results of the LAL-86 protocol].
Topics: Actuarial Analysis; Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Bone Marrow Transplantation; Carmustine; Combined Modality Therapy; Cyclophosphamide; Cytarabine; Daunorubicin; Female; Humans; Lymphoma, Non-Hodgkin; Male; Middle Aged; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Prednisone; Spain; Survival Rate; Teniposide; Thioguanine; Vincristine | 1990 |
High-dose methotrexate improves clinical outcome in children with acute lymphoblastic leukemia: St. Jude Total Therapy Study X.
Topics: Child; Child, Preschool; Clinical Trials as Topic; Female; Humans; Infant; Male; Methotrexate; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Random Allocation; Teniposide | 1988 |
52 other study(ies) available for arginine and Acute Lymphoid Leukemia
Article | Year |
---|---|
The arginine metabolome in acute lymphoblastic leukemia can be targeted by the pegylated-recombinant arginase I BCT-100.
Topics: Animals; Antineoplastic Agents; Arginase; Arginine; Cell Survival; Dexamethasone; Drug Synergism; Humans; Metabolome; Mice; Mice, Inbred NOD; Mice, SCID; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Recombinant Proteins; Xenograft Model Antitumor Assays | 2018 |
Plethysmographic and biochemical markers in the diagnosis of endothelial dysfunction in pediatric acute lymphoblastic leukemia survivors - new applications.
Topics: Adolescent; Arginine; Biomarkers; C-Reactive Protein; Child; E-Selectin; Endothelium, Vascular; Female; Humans; Male; Plethysmography; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Prospective Studies; Risk Factors; Vascular Diseases | 2018 |
Effect of donor KIR2DL1 allelic polymorphism on the outcome of pediatric allogeneic hematopoietic stem-cell transplantation.
Topics: Adolescent; Alleles; Analysis of Variance; Arginine; Child; Child, Preschool; Cysteine; Disease Progression; Disease-Free Survival; Female; Hematopoietic Stem Cell Transplantation; HLA-C Antigens; Humans; Kaplan-Meier Estimate; Leukemia, Myeloid, Acute; Male; Polymorphism, Single Nucleotide; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Receptors, KIR2DL1; Transplantation, Homologous | 2013 |
Elevated plasma ADMA contributes to development of endothelial dysfunction in children with acute lymphoblastic leukemia.
Topics: Adolescent; Arginine; Cardiovascular Diseases; Child; Child, Preschool; Endothelial Cells; Endothelium-Dependent Relaxing Factors; Enzyme Inhibitors; Female; Humans; Infant; Male; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Risk Factors | 2016 |
Elevated asymmetric dimethylarginine in young adult survivors of childhood acute lymphoblastic leukemia: a preliminary report.
Topics: Adolescent; Adult; Arginine; Cardiovascular Diseases; Female; Humans; Male; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Risk Factors; Survivors | 2012 |
Growth hormone deficiency predicts cardiovascular risk in young adults treated for acute lymphoblastic leukemia in childhood.
Topics: Adolescent; Apolipoproteins B; Arginine; Blood Glucose; Body Height; Cardiovascular Diseases; Carotid Arteries; Child; Child, Preschool; Cholesterol, LDL; Echocardiography, Doppler; Exercise; Female; Fibrinogen; Growth Hormone-Releasing Hormone; Human Growth Hormone; Humans; Infant; Insulin; Leptin; Male; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Predictive Value of Tests; Risk Factors; Triglycerides | 2004 |
The utility of the growth hormone (GH) releasing hormone-arginine test for diagnosing GH deficiency in adults with childhood acute lymphoblastic leukemia treated with cranial irradiation.
Topics: Adult; Age Factors; Arginine; Cranial Irradiation; Female; Growth Hormone-Releasing Hormone; Human Growth Hormone; Humans; Insulin; Male; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Sensitivity and Specificity | 2005 |
Growth hormone deficiency after chemotherapy for acute lymphoblastic leukemia in children who have not received cranial radiation.
Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Arginine; Body Height; Child; Child, Preschool; Clonidine; Female; Growth Disorders; Growth Hormone; Hormone Replacement Therapy; Humans; Male; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Radiotherapy; Sympatholytics | 2006 |
PMS2 mutations in childhood cancer.
Topics: Adenosine Triphosphatases; Adolescent; Arginine; Astrocytoma; Cafe-au-Lait Spots; Child; Colonic Polyps; DNA Repair; DNA Repair Enzymes; DNA-Binding Proteins; Female; Founder Effect; Genetic Predisposition to Disease; Glioma; Humans; Leukemia, T-Cell; Lymphoma, B-Cell; Lymphoma, T-Cell; Male; Mismatch Repair Endonuclease PMS2; Mutation; Neoplasms; Neoplasms, Second Primary; Pakistan; Precursor Cell Lymphoblastic Leukemia-Lymphoma; United Kingdom | 2006 |
Lack of association of the heparanase gene single-nucleotide polymorphism Arg307Lys with acute lymphoblastic leukaemia in patients from Northern Ireland.
Topics: Arginine; Case-Control Studies; Glucuronidase; Humans; Lysine; Northern Ireland; Polymorphism, Single Nucleotide; Precursor Cell Lymphoblastic Leukemia-Lymphoma | 2008 |
In vivo antitumor activity of the hypoxanthine derivatives ST 789 and ST 689.
Topics: Adjuvants, Immunologic; Animals; Antineoplastic Agents; Arginine; Cell Division; Humans; Hypoxanthines; Interleukin-6; Macrophages; Male; Mice; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Tumor Cells, Cultured | 1993 |
Arginine butyrate-induced susceptibility to ganciclovir in an Epstein-Barr-virus-associated lymphoma.
Topics: Antineoplastic Combined Chemotherapy Protocols; Antiviral Agents; Apoptosis; Arginine; Aspergillosis; Butyrates; Cyclophosphamide; Doxorubicin; Drug Synergism; Enzyme Induction; Epstein-Barr Virus Infections; Fatal Outcome; Ganciclovir; Gene Expression Regulation, Neoplastic; Gene Expression Regulation, Viral; Herpesvirus 4, Human; Humans; Lung Neoplasms; Lung Transplantation; Necrosis; Postoperative Complications; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Prednisone; Thymidine Kinase; Tumor Cells, Cultured; Vincristine; Viral Nonstructural Proteins | 1998 |
Growth hormone status in adults treated for acute lymphoblastic leukaemia in childhood.
Topics: Adolescent; Adult; Arginine; Female; Follow-Up Studies; Growth Disorders; Growth Hormone; Humans; Insulin; Male; Pituitary Irradiation; Precursor Cell Lymphoblastic Leukemia-Lymphoma | 1998 |
Arginine to lysine 108 substitution in recombinant CYP1A2 abolishes methoxyresorufin metabolism in lymphoblastoid cells.
Topics: Amino Acid Substitution; Arginine; Cytochrome P-450 CYP1A1; Cytochrome P-450 CYP1A2; Cytochrome P-450 Enzyme System; DNA, Complementary; Humans; Lysine; Models, Molecular; Mutagenesis, Site-Directed; Oxazines; Oxidoreductases; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Recombinant Proteins; Tumor Cells, Cultured | 2002 |
Effect of corticoid therapy on growth hormone secretion.
Topics: Arginine; Child; Child, Preschool; Female; Growth; Growth Hormone; Growth Hormone-Releasing Hormone; Humans; Insulin; Insulin-Like Growth Factor I; Male; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Prednisone | 1991 |
Differential effects of 18- and 24-Gy cranial irradiation on growth rate and growth hormone release in children with prolonged survival after acute lymphocytic leukemia.
Topics: Arginine; Brain; Central Nervous System Diseases; Child; Child, Preschool; Female; Growth; Growth Hormone; Humans; Levodopa; Male; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Radiation Dosage | 1988 |
Cytogenetic and molecular analysis of MLL rearrangements in acute lymphoblastic leukaemia survivors.
Topics: Adolescent; Adult; Base Sequence; Case-Control Studies; Child; Child, Preschool; Chromosomes, Human, Pair 11; Cytogenetic Analysis; Etoposide; Gene Rearrangement; Humans; Molecular Sequence Data; Myeloid-Lymphoid Leukemia Protein; Polymerase Chain Reaction; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Survivors; Teniposide; Translocation, Genetic | 2009 |
Chemotherapy for initial induction failures in childhood acute lymphoblastic leukemia: a Children's Oncology Group Study (POG 8764).
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Child; Child, Preschool; Cytarabine; Female; Humans; Hydrocortisone; Infant; Male; Methotrexate; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Remission Induction; Teniposide; Treatment Outcome; Young Adult | 2013 |
Dental abnormalities in children after chemotherapy treatment for acute lymphoid leukemia.
Topics: Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Child; Child, Preschool; Combined Modality Therapy; Cranial Irradiation; Cyclophosphamide; Cytarabine; Dental Enamel Hypoplasia; Dexamethasone; Doxorubicin; Etoposide; Female; Humans; Infant; Male; Mercaptopurine; Methotrexate; Odontogenesis; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Prednisone; Teniposide; Tooth Abnormalities; Tooth Diseases; Tooth Eruption; Tooth Root; Vincristine | 2003 |
[Significance of C-reaction protein for differential diagnosis of fever after chemotherapy on children with acute lymphoblastic leukemia].
Topics: Antimetabolites, Antineoplastic; C-Reactive Protein; Child; Child, Preschool; Cytarabine; Diagnosis, Differential; Female; Fever; Humans; Infant; Male; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Teniposide | 2004 |
[Treatment of refractory and relapsed acute lymphocytic leukemia in adults].
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Cytarabine; Female; Humans; Male; Middle Aged; Mitoxantrone; Neoplasm Recurrence, Local; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Remission Induction; Retrospective Studies; Teniposide; Treatment Outcome; Vidarabine | 2005 |
Risk of adverse events after completion of therapy for childhood acute lymphoblastic leukemia.
Topics: Antineoplastic Combined Chemotherapy Protocols; Child; Child, Preschool; Combined Modality Therapy; Cranial Irradiation; Etoposide; Female; Humans; Infant; Male; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Prognosis; Remission Induction; Risk Factors; Survival Rate; Teniposide | 2005 |
A case of fusariosis in an immunocompromised patient successfully treated with liposomal amphotericin B.
Topics: Abscess; Amphotericin B; Antibodies, Monoclonal; Antibodies, Monoclonal, Murine-Derived; Antifungal Agents; Antineoplastic Combined Chemotherapy Protocols; Benzamides; Combined Modality Therapy; Cytarabine; Foot Dermatoses; Fusarium; Humans; Imatinib Mesylate; Immunocompromised Host; Liposomes; Male; Middle Aged; Muscular Diseases; Onychomycosis; Peripheral Blood Stem Cell Transplantation; Piperazines; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Pyrimidines; Recurrence; Remission Induction; Reoperation; Rituximab; Teniposide; Triazoles; Voriconazole | 2006 |
Topoisomerase II alpha gene expression in childhood acute lymphoblastic leukemia.
Topics: Antigens, Neoplasm; Antineoplastic Combined Chemotherapy Protocols; Bone Marrow; Child; Daunorubicin; DNA Topoisomerases, Type II; DNA-Binding Proteins; Gene Expression; Humans; Isoenzymes; Lymphocytes; Precursor Cell Lymphoblastic Leukemia-Lymphoma; RNA, Messenger; Teniposide | 1995 |
Polymorphic thiopurine methyltransferase in erythrocytes is indicative of activity in leukemic blasts from children with acute lymphoblastic leukemia.
Topics: Adolescent; Aneuploidy; Antineoplastic Combined Chemotherapy Protocols; Biomarkers, Tumor; Bone Marrow; Child; Child, Preschool; Cytarabine; Erythrocytes; Female; Humans; Lymphocytes; Male; Mercaptopurine; Methotrexate; Methyltransferases; Neoplasm Proteins; Neoplastic Stem Cells; Polymorphism, Genetic; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Prognosis; Remission Induction; Teniposide; Treatment Failure | 1995 |
ALL-1 gene rearrangements in DNA topoisomerase II inhibitor-related leukemia in children.
Topics: Acute Disease; Adolescent; Bone Marrow Transplantation; Child; Child, Preschool; Chromosome Aberrations; Chromosome Deletion; Chromosomes, Human, Pair 11; Combined Modality Therapy; Dactinomycin; DNA-Binding Proteins; Etoposide; Female; Genes; Histone-Lysine N-Methyltransferase; Humans; Infant; Leukemia; Leukemia, Myeloid; Leukemia, Radiation-Induced; Male; Myelodysplastic Syndromes; Myeloid-Lymphoid Leukemia Protein; Neoplasm Proteins; Neoplasms; Neoplasms, Second Primary; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Proto-Oncogenes; Radiotherapy; Teniposide; Topoisomerase II Inhibitors; Transcription Factors; Translocation, Genetic; Whole-Body Irradiation | 1995 |
Poor outcome of intensive chemotherapy for adult acute lymphoblastic leukemia: a possible dose effect.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Cyclophosphamide; Cytarabine; Daunorubicin; Female; Humans; Leucovorin; Male; Mercaptopurine; Methotrexate; Middle Aged; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Prednisone; Prognosis; Recurrence; Remission Induction; Retrospective Studies; Survival Rate; Teniposide; Vincristine | 1994 |
On the oncology front.
Topics: Child; Female; Humans; Ovarian Neoplasms; Paclitaxel; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Teniposide | 1993 |
Successful treatment of acute lymphoblastic leukemia in a child with cystic fibrosis.
Topics: Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Child, Preschool; Cystic Fibrosis; Cytarabine; Daunorubicin; Female; Humans; Mercaptopurine; Methotrexate; Precursor B-Cell Lymphoblastic Leukemia-Lymphoma; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Prednisone; Remission Induction; Teniposide; Vincristine | 1994 |
Escalating teniposide systemic exposure to increase dose intensity for pediatric cancer patients.
Topics: Adolescent; Adult; Bayes Theorem; Child; Child, Preschool; Drug Administration Schedule; Humans; Infant; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Regression Analysis; Teniposide; Treatment Outcome | 1993 |
Teniposide granted marketing approval.
Topics: Child; Drug Approval; Humans; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Teniposide | 1993 |
Intensive alternating drug pairs for treatment of high-risk childhood acute lymphoblastic leukemia. A Pediatric Oncology Group pilot study.
Topics: Administration, Oral; Adolescent; Antineoplastic Combined Chemotherapy Protocols; Burkitt Lymphoma; Child; Child, Preschool; Cytarabine; Daunorubicin; Drug Administration Schedule; Female; Humans; Hydrocortisone; Infant; Injections, Intramuscular; Injections, Intravenous; Injections, Spinal; Leukemia-Lymphoma, Adult T-Cell; Male; Mercaptopurine; Methotrexate; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Teniposide; Treatment Failure | 1993 |
Effectiveness of intensified rotational combination chemotherapy for late hematologic relapse of childhood acute lymphoblastic leukemia.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Child; Combined Modality Therapy; Cranial Irradiation; Cytarabine; Disease-Free Survival; Drug Administration Schedule; Female; Growth Disorders; Humans; Hydrocortisone; Leukemic Infiltration; Life Tables; Male; Meninges; Methotrexate; Neoplasms, Second Primary; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Prednisone; Proportional Hazards Models; Prospective Studies; Remission Induction; Salvage Therapy; Survival Analysis; Survival Rate; Teniposide; Testis; Time Factors; Treatment Outcome; Vincristine | 1996 |
The cleavage of nuclear DNA into high molecular weight DNA fragments occurs not only during apoptosis but also accompanies changes in functional activity of the nonapoptotic cells.
Topics: Animals; Apoptosis; Cell Line; Cell Nucleus; Cell Survival; Cells, Cultured; Dexamethasone; DNA; DNA Fragmentation; DNA, Neoplasm; HeLa Cells; Humans; Mice; Mice, Inbred BALB C; Molecular Weight; Precursor Cell Lymphoblastic Leukemia-Lymphoma; T-Lymphocytes; Teniposide; Tumor Cells, Cultured | 1997 |
In vitro drug resistance profiles of adult versus childhood acute lymphoblastic leukaemia.
Topics: Adolescent; Adult; Age Factors; Antineoplastic Agents; Asparaginase; Bone Marrow Cells; Child; Child, Preschool; Cytarabine; Daunorubicin; Dexamethasone; Doxorubicin; Drug Resistance, Neoplasm; Etoposide; Female; Humans; Idarubicin; Ifosfamide; Infant; Leukemia, Prolymphocytic; Leukemia, T-Cell; Male; Mercaptopurine; Middle Aged; Mitoxantrone; Precursor B-Cell Lymphoblastic Leukemia-Lymphoma; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Prednisolone; Prognosis; Statistics, Nonparametric; Teniposide; Thioguanine; Vincristine | 2000 |
No major cognitive impairment in young children with acute lymphoblastic leukemia using chemotherapy only: a prospective longitudinal study.
Topics: Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Attention; Child, Preschool; Cognition Disorders; Cyclophosphamide; Cytarabine; Dexamethasone; Female; Follow-Up Studies; Humans; Ifosfamide; Injections, Spinal; Learning Disabilities; Longitudinal Studies; Male; Mercaptopurine; Methotrexate; Netherlands; Neuropsychological Tests; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Prednisone; Prospective Studies; Survivors; Teniposide; Treatment Outcome; Vincristine | 2002 |
DNA topoisomerase II immunostaining in human leukemia and rhabdomyosarcoma cell lines and their responses to topoisomerase II inhibitors.
Topics: Cell Division; Cell Line; DNA Topoisomerases, Type II; Humans; Immunoenzyme Techniques; Kinetics; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Rhabdomyosarcoma; Teniposide; Time Factors; Topoisomerase II Inhibitors; Tumor Cells, Cultured | 1992 |
[Allergic reactions to teniposide (VM-26) in children with neoplasms].
Topics: Adolescent; Child; Child, Preschool; Drug Hypersensitivity; Female; Histiocytosis, Langerhans-Cell; Humans; Male; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Teniposide | 1992 |
Teniposide for acute lymphoblastic leukemia.
Topics: Child; Drug Interactions; Humans; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Teniposide | 1992 |
Variability in teniposide plasma protein binding is correlated with serum albumin concentrations.
Topics: Adolescent; Adult; Blood Proteins; Body Weight; Child; Child, Preschool; Female; Humans; Infant; Male; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Protein Binding; Remission Induction; Serum Albumin; Teniposide | 1992 |
Expression of a mutant DNA topoisomerase II in CCRF-CEM human leukemic cells selected for resistance to teniposide.
Topics: Alleles; Amino Acid Sequence; Animals; Base Sequence; Cloning, Molecular; DNA Topoisomerases, Type II; Drug Resistance; Gene Expression; Humans; Molecular Sequence Data; Mutation; Oligonucleotide Probes; Polymerase Chain Reaction; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Sequence Homology, Nucleic Acid; Teniposide | 1991 |
Acute nonlymphoblastic leukemia in children treated for acute lymphoblastic leukemia with an intensive regimen including teniposide.
Topics: Child, Preschool; Female; Humans; Immunophenotyping; Leukemia, Myeloid, Acute; Male; Neoplasms, Second Primary; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Teniposide | 1992 |
Differences in teniposide disposition and pharmacodynamics in patients with newly diagnosed and relapsed acute lymphocytic leukemia.
Topics: Adolescent; Adult; Bilirubin; Blood Proteins; Child; Child, Preschool; Female; Humans; Infant; Male; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Protein Binding; Remission Induction; Serum Albumin; Teniposide | 1992 |
Increased teniposide clearance with concomitant anticonvulsant therapy.
Topics: Adolescent; Anticonvulsants; Child; Child, Preschool; Chromatography, High Pressure Liquid; Drug Interactions; Female; Humans; Male; Metabolic Clearance Rate; Phenobarbital; Phenytoin; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Teniposide | 1992 |
Somnolence, hypotension, and metabolic acidosis following high-dose teniposide treatment in children with leukemia.
Topics: Acidosis; Antineoplastic Combined Chemotherapy Protocols; Child; Child, Preschool; Cytarabine; Diphenhydramine; Drug Administration Schedule; Female; Humans; Hypotension; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Remission Induction; Sleep Wake Disorders; Teniposide | 1991 |
Hypersensitivity reactions to epipodophyllotoxins in children with acute lymphoblastic leukemia.
Topics: Adolescent; Adrenal Cortex Hormones; Antineoplastic Combined Chemotherapy Protocols; Bronchial Spasm; Child; Child, Preschool; Cyanosis; Diphenhydramine; Dose-Response Relationship, Drug; Drug Hypersensitivity; Etoposide; Female; Humans; Hypotension; Infant; Male; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Premedication; Teniposide | 1991 |
Acute respiratory failure after intrathecal methotrexate administration.
Topics: Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Cytarabine; Doxorubicin; Female; Humans; Infant; Injections, Spinal; Methotrexate; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Respiratory Insufficiency; Teniposide | 1990 |
Multiagent chemotherapy in relapsed acute lymphoblastic leukemia in children.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Child; Child, Preschool; Cytarabine; Daunorubicin; Female; Humans; Hydrocortisone; Infant; Male; Methotrexate; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Prednisone; Recurrence; Remission Induction; Teniposide; Vincristine | 1990 |
Increased ATP requirement for activity of and complex formation by DNA topoisomerase II from human leukemic CCRF-CEM cells selected for resistance to teniposide.
Topics: Adenosine Triphosphate; Adenylyl Imidodiphosphate; Amsacrine; Cell Line; Cell Nucleus; DNA Topoisomerases, Type I; DNA, Neoplasm; Drug Resistance; Humans; Kinetics; Podophyllotoxin; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Protein Binding; Teniposide; Tumor Cells, Cultured | 1989 |
Effective reinduction therapy for childhood acute nonlymphoid leukemia using simultaneous continuous infusions of teniposide and amsacrine.
Topics: Adolescent; Adult; Amsacrine; Antineoplastic Combined Chemotherapy Protocols; Blast Crisis; Child; Child, Preschool; Drug Evaluation; Female; Humans; Infant; Infusions, Intravenous; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Leukemia, Myeloid, Acute; Leukopenia; Male; Mouth Mucosa; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Remission Induction; Stomatitis; Teniposide; Thrombocytopenia | 1989 |
[Cytosine arabinoside and VM-26 in induction treatment, failures and recurrences of childhood acute lymphoblastic leukemias].
Topics: Child; Child, Preschool; Cytarabine; Drug Combinations; Female; Humans; Male; Podophyllotoxin; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Recurrence; Remission Induction; Risk Factors; Teniposide | 1988 |
Deoxycoformycin treatment for childhood T-cell acute lymphoblastic leukemia early in second remission: a Pediatric Oncology Group Study.
Topics: Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Child; Coformycin; Cytarabine; Daunorubicin; Humans; Pentostatin; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Prednisone; Ribonucleosides; T-Lymphocytes; Teniposide; Vincristine | 1988 |